SpaceX's 12th test flight of the Starship did not achieve a complete success, as the failure to recover the booster left a notable shortfall in the mission. However, analysts and investors have concluded that it was sufficient.
On May 22, SpaceX conducted the 12th test flight of Starship from its Starbase facility in Texas, marking the inaugural flight of the V3 iteration. The vehicle successfully deployed a batch of simulated satellites and executed a controlled splashdown in the Indian Ocean. However, the recovery of the "Super Heavy" booster failed, resulting in its descent into the Gulf of Mexico. Reports indicate that SpaceX's IPO roadshow is scheduled to commence on June 4. If the offering proceeds smoothly, it could raise up to $80 billion, potentially setting a record for the largest IPO in history.
Analysts have characterized this test as a "lukewarm success"—neither a complete failure nor a comprehensive breakthrough. Following a seven-month hiatus since the last flight, the mere completion of the test served to reassure the market. Mark Vena, CEO of SmartTech Research, noted, "SpaceX did not need this flight to be perfect. It needed to demonstrate that the upgraded vehicle is progressing in the right direction, and investors largely saw that."
The SpaceX IPO has ignited enthusiasm for space ventures on Wall Street. On Tuesday, shares of space infrastructure company Redwire surged by as much as 31%, closing up 26%, while Firefly Aerospace soared 19% after securing a NASA lunar contract. The Bank of America Space Index has skyrocketed 61% year-to-date, and the Procure Space ETF has gained nearly 69%, far outpacing the S&P 500's 9.8% increase. Investors are increasingly evaluating SpaceX within a broader framework, positioning it as a future provider of AI infrastructure. However, whether Starship can operate reliably on a commercial scale remains a key point of debate between bulls and bears.
"Lukewarm Success"
SpaceX's 12th Starship test since 2023 presented a clear mix of outcomes.
On the positive side, the V3 vehicle successfully completed its simulated satellite deployment mission and achieved a controlled splashdown in the Indian Ocean. On the downside, the "Super Heavy" booster, a core reusable component, failed to execute a controlled landing as planned, ultimately crashing into the Gulf of Mexico.
Antoine Grenier, Partner and Head of Space Consulting at Analysys Mason, described the "lukewarm success" as "a good outcome, perhaps even the best outcome." He explained, "A complete failure would have been problematic, while a full success could have triggered overly exuberant market sentiment ahead of the IPO."
SpaceX has invested over $15 billion in the development of Starship, aiming to create a fully reusable heavy-lift rocket with capabilities far exceeding current launch systems. For now, this goal remains a "work in progress."
Critical Window Before IPO
SpaceX had been silent for seven months since the last Starship test. Analysts note that this hiatus made conducting a test before the IPO almost a necessity.
Antoine Grenier stated that failing to launch before the IPO "would have raised more questions from investors about the company's execution pace." From this perspective, the mere completion of the test holds symbolic significance comparable to the test results themselves.
The strategic value of Starship extends far beyond launch services. In its IPO filing, SpaceX emphasized that Starship is crucial for reducing launch costs, expanding the Starlink satellite internet business (currently the company's core cash source), and supporting the deployment of orbital AI data center satellites, crewed lunar missions, and even Mars exploration. If the roadshow proceeds smoothly, the offering could reach up to $80 billion, surpassing all previous IPO records.
The Bull Case: From Rocket to AI Infrastructure
Bullish sentiment among investors and analysts remained largely undeterred by the test's imperfections, underpinned by a broader investment narrative.
James Bruegger, Chief Investment Officer at UK investment firm Seraphim Space, stated, "Full reusability is key to dramatically lowering launch costs, and that is where the real value lies."
Investors are increasingly viewing SpaceX as a potential core provider of AI infrastructure, betting on space-based computing scenarios such as orbital data centers and next-generation satellite constellations. This week, Musk also endorsed his AI company xAI, noting that the three-year-old firm is still in its early stages compared to OpenAI and Anthropic, and promising that its models "will be very good."
Jesse Nacht, a researcher at MarketVector Indexes, commented, "This launch reduced the tail risk of Starship falling into a failure loop but did not entirely eliminate execution risk. Unless a catastrophic accident occurs, I don't believe it will significantly alter market expectations."
Execution Risks Remain
Despite an overall bullish market sentiment, analysts widely emphasize that Starship still has considerable ground to cover before it can operate reliably and economically on a commercial scale.
Austin Moeller, Executive Director of Equity Research at Canaccord Genuity, pointed out, "SpaceX clearly needs to demonstrate successful launch, payload deployment, orbit insertion, and controlled landings of both the booster and the vehicle to enable system scalability and the construction of a super-constellation of orbital data centers."
In its IPO filing, SpaceX also cautioned that delays in development or cost targets could increase operational expenses, thereby hindering the deployment pace of next-generation satellites and AI infrastructure. Some investors worry that Starship could become trapped in a "fix-fail" cycle, never validating an end-to-end usable system.
For the market, this test provided an incremental confirmation of confidence rather than a decisive technological breakthrough. Whether the booster can achieve stable recovery and rapid re-flight turnaround in subsequent missions will remain a core metric for investors to monitor during the roadshow period.
Comments